InvestorsHub Logo

abew4me

11/06/23 9:54 AM

#438178 RE: Hoskuld #438177

I never said that he was new. I was quoting Bourbon's post so he could reflect on his comments.

Don't take things out of context.

vg_future

11/06/23 10:02 AM

#438180 RE: Hoskuld #438177

Yes, the best and obvious explanation. Folks are trying to rip into it in a desperate attempt to spread the FUD. Also, regarding Fadiran, for all that we know he might have done what he was brought in for....preparing the data and paperwork for submissions (folks have to remember that he cannot create the data...that is another part of the company...he can only arrange it in the best possible way). He might have left for personal reasons (company doesn't have to divulge that info) and the new guy came to take over (with the one year ramp up). Folks saying otherwise and pissing all over the place know jack shit and are just bunch of armchair CEOs who can only babble non-sense here.

JMHO,
vg_future

tredenwater2

11/06/23 10:37 AM

#438185 RE: Hoskuld #438177

He was hired a year ago to transition into the lead role as Dr. Fadiran retires. This is far from a controversial move - this is good transition planning.



Yes indeed. With as many trials underway and NDA(s) preparation nearing, these things take time to transition in new VP’s. This change in my my mind is a positive normal progression. Dr. Fadirian has done much early heavy lifting for Anavex and should be commended instead of mocked (not by you) but hey, what ever floats the naysayers boats so be it.

Everyone has their time on earth, hopefully its rewarding and fruitful.